SCHEMBL13898952

SCHEMBL13898952

CC(C)CN(C(C)(C)C(=O)NO)S(=O)(=O)c1ccc(Oc2ccc(S(C)(=O)=O)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.47
MMP2 P08253 12/20 0.47
MMP13 P45452 12/20 0.47
MMP1 P03956 9/20 0.46
MMP3 P08254 7/20 0.46
MCL1 Q07820 1/20 0.44
MMP9 P14780 4/20 0.43
MMP14 P50281 3/20 0.43
MMP8 P22894 2/20 0.43
MMP16 P51512 1/20 0.42
ADAM17 P78536 1/20 0.42
ADAMTS4 O75173 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
BMP1 P13497 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13899011 0.87 LMNA (0.47) MMP2MMP13MMP1MMP3MMP9
SCHEMBL3921655 0.84 MMP2 (0.47) MMP2MMP13MMP1MMP3MMP9
SCHEMBL13899009 0.82 MMP13 (0.52) MMP2MMP13MMP1MMP3MMP9
SCHEMBL13898736 0.81 BMP1 (0.48) MMP2MMP13MMP1MMP3MMP9
SCHEMBL13899003 0.78 MMP3 (0.74) MMP2MMP13MMP1MMP3MMP9
SCHEMBL3914725 0.75 MMP2 (0.67) MMP2MMP13MMP1MMP3MMP9
SCHEMBL3914722 0.75 MMP2 (0.67) MMP2MMP13MMP1MMP3MMP9
SCHEMBL231737 0.74 MMP1 (0.55) MMP2MMP13MMP1MMP3MMP9
SCHEMBL6817940 0.74 MMP1 (0.48) MMP2MMP13MMP1MMP3MMP9
SCHEMBL3914343 0.72 MMP1 (0.60) RORCMMP2MMP13MMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504537-B2 Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-03-17 US disclosed
US-7504537-B2 Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-03-17 US disclosed